Skip to main content

Find Clinical Trials

Home
Conditions
Marginal Zone B Cell Lymphoma

Clinical trial condition

Marginal Zone B Cell Lymphoma

Explore clinical trials studying Marginal Zone B Cell Lymphoma. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Marginal Zone B Cell Lymphoma trial results

Recruiting

Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

NCT06806488

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy

View Trial Details

Not Yet Recruiting

A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

NCT07713459

Conditions: CAR T Cell Therapy, Diffuse Large B Cell Lymphoma (DLBCL), Follicular B-cell Non-Hodgkin's Lymphoma, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors

NCT07592481

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma

NCT07024147

Conditions: B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
Locations: Beijing cancer hospital Beijing, Beijing Municipality, China

View Trial Details